Literature DB >> 6756322

Synthesis of IgM, IgG and IgA in rheumatoid arthritis.

K Poikonen, M Oka, T Möttönen, I Jokinen, H Arvilommi.   

Abstract

We studied the production of immunoglobulins by lymphocytes separated from the blood of 15 rheumatoid arthritis (RA) patients, of 12 patients suffering from other connective tissue diseases (CTD), and of 18 healthy controls. The production of IgM, IgG and IgA in pokeweed-mitogen-stimulated cultures was measured by counting the number of plaque-forming cells (PFC) and by determining the concentration of secreted immunoglobulins by means of an enzyme immunoassay. Synthesis of immunoglobulins, particularly IgM and IgG, was lower than in other CTD patients or controls. The IgM response of RA patients was 20% and 29% (PFC and Ig concentrations) that of the controls. The respective figures for IgG were 33% and 53% and for IgA 61% and 72%.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6756322      PMCID: PMC1000994          DOI: 10.1136/ard.41.6.607

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  13 in total

1.  Depressed primary in vitro antibody response in rheumatoid arthritis.

Authors:  P Segond; J F Delfraissy; P Galanaud; C Wallon; P Massias; J Dormont
Journal:  Clin Exp Immunol       Date:  1979-08       Impact factor: 4.330

2.  The use of the enzyme-linked immunosorbent assay (ELISA) for the detection and quantification of specific antibody from cell cultures.

Authors:  B S Kelly; J G Levy; L Sikora
Journal:  Immunology       Date:  1979-05       Impact factor: 7.397

Review 3.  Cellular immunological aspects of rheumatoid arthritis.

Authors:  D T Yu; J B Peter
Journal:  Semin Arthritis Rheum       Date:  1974       Impact factor: 5.532

4.  Immunologic reactivity in rheumatoid arthritis. Response to mitogens.

Authors:  E M Lance; S C Knight
Journal:  Arthritis Rheum       Date:  1974 Sep-Oct

5.  A plaque assay for all cells secreting Ig of a given type or class.

Authors:  E Gronowicz; A Coutinho; F Melchers
Journal:  Eur J Immunol       Date:  1976-08       Impact factor: 5.532

6.  Role of polyclonal activation in specific immune responses. Relevance for findings of antibody activity in various diseases.

Authors:  E Möller; H Ström; S Al-Balaghi
Journal:  Scand J Immunol       Date:  1980       Impact factor: 3.487

7.  Impaired immunoglobulin M synthesis by peripheral blood lymphocytes in systemic lupus erythematosus: a primary B-cell defect.

Authors:  K M Nies; R H Stevens; J S Louie
Journal:  Clin Immunol Immunopathol       Date:  1981-04

8.  Lymphocyte response to mitogens in rheumatoid arthritis [proceedings].

Authors:  R J Haines; D Hough
Journal:  Biochem Soc Trans       Date:  1978       Impact factor: 5.407

9.  Cell mediated immunity in rheumatoid arthritis: Imparied lymphocyte responsiveness, humoral immunosuppressants, and correlations with clinical status in patients off drug therapy.

Authors:  T M Lloyd; R S Panush
Journal:  J Rheumatol       Date:  1977       Impact factor: 4.666

10.  Pokeweed mitogen induced differentiation of human B cells: evaluation by a protein A haemolytic plaque assay.

Authors:  L Hammarström; A G Bird; S Britton; C I Smith
Journal:  Immunology       Date:  1979-09       Impact factor: 7.397

View more
  10 in total

1.  Analysis of impaired in vitro immunoglobulin synthesis in rheumatoid arthritis.

Authors:  I Jokinen; K Poikonen; T Möttönen; P Hannonen; M Oka; J Ilonen; H M Surcel; R Karttunen; H Arvilommi
Journal:  Ann Rheum Dis       Date:  1990-07       Impact factor: 19.103

2.  Polyclonal antibody formation of human lymphocytes to bacterial components.

Authors:  L Räsänen; M Lehto; I Jokinen; P Leinikki
Journal:  Immunology       Date:  1986-08       Impact factor: 7.397

3.  Adsorption of anti-dsDNA antibodies by immobilized polyanionic compounds.

Authors:  S Aotsuka; T Funahashi; N Tani; M Okawa-Takatsuji; M Kinoshita; R Yokohari
Journal:  Clin Exp Immunol       Date:  1990-02       Impact factor: 4.330

4.  IgM, IgG, and IgA synthesis in vitro in persons suffering from yersinia arthritis and in patients with ankylosing spondylitis.

Authors:  R Vuento; J Eskola; R Leino; S Koskimies; M Viander
Journal:  Ann Rheum Dis       Date:  1984-04       Impact factor: 19.103

5.  Defective monocyte accessory function due to surface sulphydryl (SH) oxidation in rheumatoid arthritis.

Authors:  M J McKeown; N D Hall; J R Corvalan
Journal:  Clin Exp Immunol       Date:  1984-06       Impact factor: 4.330

6.  In vitro synthesis of IgM and IgM rheumatoid factor in seronegative arthritides.

Authors:  G S Alarcón; W J Koopman; R E Schrohenloher
Journal:  Rheumatol Int       Date:  1984       Impact factor: 2.631

7.  Selenium and immune functions in humans.

Authors:  H Arvilommi; K Poikonen; I Jokinen; O Muukkonen; L Räsänen; J Foreman; J K Huttunen
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

8.  Effects of a human urinary mitogen on subpopulations of peripheral blood mononuclear leukocytes.

Authors:  A G Wangel; K Kayhko; S Reitamo; I Jokinen
Journal:  Clin Exp Immunol       Date:  1986-10       Impact factor: 4.330

9.  Cross-reactive rheumatoid factors in rheumatoid arthritis with extra-articular disease.

Authors:  M Kinoshita; S Aotsuka; R Yokohari
Journal:  Clin Exp Immunol       Date:  1990-01       Impact factor: 4.330

10.  Analysis of negatively charged dye-binding antibodies reactive with double-stranded DNA and heparan sulfate in serum from patients with rheumatic diseases.

Authors:  S Aotsuka; M Okawa-Takatsuji; M Kinoshita; R Yokohari
Journal:  Clin Exp Immunol       Date:  1988-09       Impact factor: 4.330

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.